Daily non-political popular news in brief.

High-dose inhaled corticosteroid use for COPD could cut risk of lung cancer

Among a group of mostly older male veterans suffering from chronic obstructive pulmonary disease (COPD), an illness that offers greater susceptibility to lung cancer, researchers found that the regular use of high-dose inhaled corticosteroids (ICS) lowered the risk of developing lung cancer.

Read more »

Keywords: high-dose, inhaled, corticosteroid, copd, cut, risk, lung, cancer, high, dose

« Previous | Next »

Similar news on "High-dose inhaled corticosteroid use for COPD could cut risk of lung cancer":

1. Personalized medicine can cut breast cancer risk
   02-15-2008 · EurekAlert!
   The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care. A growing body of evidence has documented the benefits of preventive measures for high-risk women including those with mutations in the BRCA1 and BRCA2 genes. Referral for cancer-risk assessment and BRCA testing in the primary care setting is a necessary step towards personalized medicine for women at risk.
   Similar news · Read more »
   
2. Other highlights in the February 21 JNCI
   02-20-2007 · EurekAlert!
   Also in the February 21 JNCI are a new screening method for those at risk for a hereditary colorectal cancer, a mouse study of low-dose bisphosphonates' antitumor effects, and research on a protein that is active in metastasis suppression.
   Similar news · Read more »
   
3. GSK announces launch of largest ever Phase III trial in lung cancer treatment
   06-05-2007 · EurekAlert!
   GlaxoSmithKline today announced final results of a Phase II clinical trial of its investigational Antigen-Specific Cancer Immunotherapeutic MAGE-A3 in non small cell lung cancer. Final trial analysis showed a 27 percent reduction in the relative risk of cancer recurrence following surgery, compared to placebo. GSK also announced today the launch of a Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment.
   Similar news · Read more »
   
4. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
   08-16-2007 · EurekAlert!
   Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer, according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine today.
   Similar news · Read more »
   
5. Radiation seed implant decreases risk of death over watchful waiting
   10-31-2007 · EurekAlert!
   Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants to treat their cancer, compared to those who don't receive active treatment, within six months from being diagnosed with localized prostate cancer, according to a study presented Oct. 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
   Similar news · Read more »
   
6. Putting risk in perspective: Do people make better decisions when they understand average risk?
   12-13-2007 · EurekAlert!
   If there were a pill that would cut your risk of breast cancer in half, would you take it? What if you were told your risk of breast cancer was already below average? In a newly published survey, women who were told their risk of breast cancer was above average were more likely to endorse taking the hypothetical pill than women who were told their risk was below average.
   Similar news · Read more »
   
7. Passive smoke in workplace increases lung cancer risk
   01-31-2007 · EurekAlert!
   An analysis of nearly two dozen studies confirms the association between passive smoke in the workplace and an increased risk of lung cancer, according to a report in the American Journal of Public Health.
   Similar news · Read more »
   
8. Breast cancer survival rates improved by novel drug sequence, say researchers
   02-12-2007 · EurekAlert!
   Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
   Similar news · Read more »
   
9. Protein may be linked to melanoma recurrence
   06-02-2007 · EurekAlert!
   Higher levels of a protein called S-100 in melanoma patients may correlate with a higher risk of the disease returning, say researchers at the University of Pittsburgh Cancer Institute. The study tested serum samples from 103 patients treated with high-dose interferon an average of eight years prior. When the researchers examined levels of S-100 in the samples, they found that the higher the level of the protein, the greater likelihood the disease had returned.
   Similar news · Read more »
   
10. New report shows how our diet must change to cut cancer risk
    11-01-2007 · EurekAlert!
    A new report published this week by the World Cancer Research Fund will show how much our diet needs to change if we are to reduce the risk of cancer.
    Similar news · Read more »